ERIN SPANGLER: Open Payments
NPI 1265921589 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 15 payments from 8 companies in 2025. Trend: 2023 $169 · 2024 $140 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 2 | $163 |
| Lilly USA, LLC | 3 | $160 |
| Eisai Inc. | 2 | $111 |
| Lundbeck LLC | 3 | $64 |
| ABBVIE INC. | 2 | $47 |
| Genentech USA, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ARGENX US, INC. | 1 | $19 |
Products named: BRIUMVI, KISUNLA, Leqembi, VYEPTI, DALVANCE, Ocrevus Zunovo, HYQVIA, VYVGART HYTRULO.
Industry payments across LA — which companies pay providers there.
